Teradyne, Inc. (TER)
Valuation Overview•Is Teradyne, Inc. Overvalued or Undervalued?
Commands a premium valuation multiple over its peers, likely pricing in superior execution.
High-quality fundamentals with a strong composite quality score of 80/100, backed by robust profitability and solvency.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: High-quality compounder, with growth as the only relative weakness.
Wall Street is highly bullish, projecting significant upside alongside robust expected earnings growth. However, capital return yields remain modest, driven predominantly by aggressive share repurchases.
Returns capital exclusively via buybacks — no active dividend
TER exhibits elite business quality, driven by exceptional capital efficiency and highly lucrative margins. This is supported by a highly conservative balance sheet featuring strong liquidity and pristine Altman Z safety.
The company exhibits steady, low-single-digit revenue growth however, earnings have severely contracted over the same period. This growth is supported by elite operational efficiency, sustaining an impressive 30.6% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | +13.1% | +0.4% | +0.4% | +6.9% | |
| EBITDA | $471.4M | — | -4.5% | — | — | |
| Net Income | $374.5M | +2.2% | -8.2% | — | +10.4% | |
| EPS (Diluted) | $2.38 | +4.8% | -6.2% | -4.1% | +13.6% | |
| Free Cash Flow | $378.4M | -5.0% | +2.8% | -8.0% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 59.3% | 58.1% | 58.6% | 57.9% |
| Operating Margin | 30.6% | 20.5% | 24.1% | 21.8% |
| Net Margin | 25.8% | 17.8% | 20.7% | 18.0% |
| FCF Margin | 17.9% | 15.6% | 17.2% | 19.0% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q3'26Latest | $2.09 | $2.47 | +18.2% | ||
| Q2'26 | $2.11 | $2.56 | +21.3% | ||
| Q1'26 | $1.38 | $1.80 | +30.4% | ||
| Q4'25 | $0.79 | $0.85 | +7.6% | ||
| Q3'25 | $0.54 | $0.57 | +5.2% | ||
| Q2'25 | $0.62 | $0.75 | +21.2% | ||
| Q1'25 | $0.91 | $0.95 | +4.4% | ||
| Q4'24 | $0.79 | $0.90 | +13.9% |
Total return is +195.3% (1Y), outperforming the benchmark by +179.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +92.3% | +79.1% | — |
| 1Y | +195.3% | +179.3% | +0.4% |
| 3YCAGR | +61.3% | +37.2% | +1.5% |
| 5YCAGR | +27.7% | +15.0% | +2.0% |
| 10YCAGR | +34.0% | +20.0% | — |
The S&P 500 is at 31.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Teradyne, Inc. (TER) valuation, health, and returns.
Teradyne, Inc. is estimated to be fair under our discounted cash flow framework. relative multiples indicate the stock is Slightly expensive versus peers compared to industry peers. trading near fair value (DCF: $308.57)
Teradyne, Inc. has multiple valuation anchors: DCF Intrinsic Value: $308.57 | Peer Relative Fair Value: $306.70 | Wall Street Analyst Target: $461.50 (implying +15.8% upside). A convergence of these signals offers higher conviction.
Teradyne, Inc. displays excellent financial health with a composite quality score of 80/100, supported by a Altman Z-Score of 29.3 (safe zone), Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 19.8%.
Teradyne, Inc. returns capital via buybacks instead of dividends, carrying a 1.1% buyback yield and reducing outstanding shares by -3.5% in the last 12 months.
Teradyne, Inc.'s current growth trajectory is Accelerating. The company achieved +13.1% 1Y revenue growth and +4.8% 1Y EPS growth, compared to its 3Y revenue CAGR of +0.4%.
Wall Street consensus is Buy based on 31 analysts, beating EPS expectations in 100% of recent quarters with a 41-quarter streak. The consensus price target represents a +15.8% change from current levels.
Investment risks for Teradyne, Inc. include: -34.0% 1-year max drawdown, high beta (3.30x market volatility). Volatility risk is characterized by a beta of 3.30x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.